Giovanni Caforio Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Giovanni Caforio.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Giovanni Caforio. Giovanni Caforio is Chief Operating Officer in BRISTOL MYERS SQUIBB CO ($BMY) and EVP & Chief Commercial Officer in BRISTOL MYERS SQUIBB CO ($BMY) and Pres., US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY).
Latest Insider Trading Transactions of Giovanni Caforio
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2015 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Jan 06 2015 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Chief Operating Off ... | Payment of Exercise | F | 59.51 | 2,855 | 169,901 | 45,399 | 48.3 K to 45.4 K (-5.92 %) |
| Jan 06 2015 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Chief Operating Off ... | Buy | M | 0.00 | 7,500 | 0 | 48,254 | 40.8 K to 48.3 K (+18.40 %) |
| Sep 16 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Chief Operating Off ... | Sell | S | 49.87 | 26,691 | 1,331,155 | 40,755 | 67.4 K to 40.8 K (-39.57 %) |
| Mar 12 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 22,807 | 0 | 22,807 | |
| Mar 12 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 4,878 | 0 | 14,635 | |
| Mar 12 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 56.14 | 3,678 | 206,483 | 67,446 | 71.1 K to 67.4 K (-5.17 %) |
| Mar 12 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | J | 0.00 | 2,214 | 0 | 71,124 | 68.9 K to 71.1 K (+3.21 %) |
| Mar 12 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 4,878 | 0 | 68,910 | 64 K to 68.9 K (+7.62 %) |
| Mar 10 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 2,889 | 0 | 5,778 | |
| Mar 10 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 55.56 | 2,516 | 139,789 | 64,032 | 66.5 K to 64 K (-3.78 %) |
| Mar 10 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | J | 0.00 | 1,962 | 0 | 66,548 | 64.6 K to 66.5 K (+3.04 %) |
| Mar 10 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 2,889 | 0 | 64,586 | 61.7 K to 64.6 K (+4.68 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | J | 0.00 | 309 | 0 | 10,216 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 9,907 | 0 | 9,907 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | J | 0.00 | 408 | 0 | 13,501 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 5,868 | 0 | 13,092 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 16,184 | 0 | 0 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | J | 0.00 | 489 | 0 | 16,184 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 7,504 | 0 | 15,695 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 1,494 | 0 | 1,494 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 1,197 | 0 | 0 | |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 53.49 | 6,830 | 365,337 | 61,697 | 68.5 K to 61.7 K (-9.97 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 16,184 | 0 | 68,527 | 52.3 K to 68.5 K (+30.92 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 53.49 | 1,550 | 82,910 | 52,343 | 53.9 K to 52.3 K (-2.88 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | J | 0.00 | 1,494 | 0 | 53,893 | 52.4 K to 53.9 K (+2.85 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 1,494 | 0 | 52,399 | 50.9 K to 52.4 K (+2.93 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 53.49 | 1,242 | 66,435 | 50,905 | 52.1 K to 50.9 K (-2.38 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | J | 0.00 | 1,197 | 0 | 52,147 | 51 K to 52.1 K (+2.35 %) |
| Mar 05 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 1,197 | 0 | 50,950 | 49.8 K to 51 K (+2.41 %) |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 17.51 | 39,363 | 689,246 | 0 | |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Sell | S | 54.59 | 1,976 | 107,870 | 49,753 | 51.7 K to 49.8 K (-3.82 %) |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Sell | S | 54.58 | 400 | 21,832 | 51,729 | 52.1 K to 51.7 K (-0.77 %) |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Sell | S | 54.57 | 12,572 | 686,054 | 52,129 | 64.7 K to 52.1 K (-19.43 %) |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Sell | S | 54.36 | 26,615 | 1,446,882 | 64,701 | 91.3 K to 64.7 K (-29.15 %) |
| Feb 25 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 17.51 | 39,363 | 689,246 | 91,316 | 52 K to 91.3 K (+75.77 %) |
| Jan 06 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
| Jan 06 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Payment of Exercise | F | 52.85 | 2,864 | 151,362 | 51,953 | 54.8 K to 52 K (-5.22 %) |
| Jan 06 2014 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | EVP & Chief Commerc ... | Buy | M | 0.00 | 7,500 | 0 | 54,817 | 47.3 K to 54.8 K (+15.85 %) |
| May 31 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Sell | S | 47.06 | 10,538 | 495,918 | 47,316 | 57.9 K to 47.3 K (-18.21 %) |
| May 23 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 25.45 | 21,333 | 542,925 | 0 | |
| May 23 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Sell | S | 46.29 | 26,647 | 1,233,490 | 57,854 | 84.5 K to 57.9 K (-31.53 %) |
| May 23 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 25.45 | 21,333 | 542,925 | 84,501 | 63.2 K to 84.5 K (+33.77 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 19,513 | 0 | 19,513 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | J | 0.00 | 277 | 0 | 7,224 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 6,947 | 0 | 6,947 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | J | 0.00 | 314 | 0 | 8,191 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 3,553 | 0 | 7,877 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 9,902 | 0 | 0 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | J | 0.00 | 378 | 0 | 9,902 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 2,879 | 0 | 9,524 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 2,889 | 0 | 8,667 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,197 | 0 | 1,197 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,494 | 0 | 2,988 | |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 37.53 | 4,278 | 160,553 | 63,169 | 67.4 K to 63.2 K (-6.34 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 37.53 | 1,225 | 45,974 | 67,447 | 68.7 K to 67.4 K (-1.78 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 37.53 | 802 | 30,099 | 68,672 | 69.5 K to 68.7 K (-1.15 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 37.53 | 667 | 25,033 | 69,474 | 70.1 K to 69.5 K (-0.95 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | J | 0.00 | 399 | 0 | 70,141 | 69.7 K to 70.1 K (+0.57 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | J | 0.00 | 591 | 0 | 69,742 | 69.2 K to 69.7 K (+0.85 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | J | 0.00 | 658 | 0 | 69,151 | 68.5 K to 69.2 K (+0.96 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,197 | 0 | 68,493 | 67.3 K to 68.5 K (+1.78 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,494 | 0 | 67,296 | 65.8 K to 67.3 K (+2.27 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 2,889 | 0 | 65,802 | 62.9 K to 65.8 K (+4.59 %) |
| Mar 11 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 9,902 | 0 | 62,913 | 53 K to 62.9 K (+18.68 %) |
| Mar 05 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,851 | 0 | 0 | |
| Mar 05 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 37.15 | 690 | 25,634 | 53,011 | 53.7 K to 53 K (-1.28 %) |
| Mar 05 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,851 | 0 | 53,701 | 51.9 K to 53.7 K (+3.57 %) |
| Feb 27 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Sell | S | 37.08 | 12,150 | 450,522 | 51,850 | 64 K to 51.9 K (-18.98 %) |
| Jan 28 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 28.67 | 22,500 | 645,075 | 0 | |
| Jan 28 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Sell | S | 36.19 | 20,350 | 736,467 | 64,000 | 84.4 K to 64 K (-24.13 %) |
| Jan 28 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 28.67 | 22,500 | 645,075 | 84,350 | 61.9 K to 84.4 K (+36.38 %) |
| Jan 07 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
| Jan 07 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 33.24 | 2,910 | 96,728 | 61,850 | 64.8 K to 61.9 K (-4.49 %) |
| Jan 07 2013 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 7,500 | 0 | 64,760 | 57.3 K to 64.8 K (+13.10 %) |
| Aug 28 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 23.18 | 30,458 | 705,925 | 0 | |
| Aug 28 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Sell | S | 32.69 | 25,900 | 846,671 | 57,260 | 83.2 K to 57.3 K (-31.14 %) |
| Aug 28 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 23.18 | 30,458 | 705,925 | 83,160 | 52.7 K to 83.2 K (+57.79 %) |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | J | 0.00 | 186 | 0 | 4,324 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 4,138 | 0 | 4,138 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | J | 0.00 | 215 | 0 | 6,645 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 3,353 | 0 | 6,430 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 8,811 | 0 | 0 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 3,142 | 0 | 8,811 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | A | 0.00 | 11,556 | 0 | 11,556 | |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 32.33 | 3,204 | 103,585 | 52,702 | 55.9 K to 52.7 K (-5.73 %) |
| Mar 08 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 8,811 | 0 | 55,906 | 47.1 K to 55.9 K (+18.71 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,517 | 0 | 0 | |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,851 | 0 | 1,851 | |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,197 | 0 | 2,394 | |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 1,493 | 0 | 4,482 | |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 32.59 | 552 | 17,990 | 47,095 | 47.6 K to 47.1 K (-1.16 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,517 | 0 | 47,647 | 46.1 K to 47.6 K (+3.29 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 32.59 | 673 | 21,933 | 46,130 | 46.8 K to 46.1 K (-1.44 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,851 | 0 | 46,803 | 45 K to 46.8 K (+4.12 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 32.59 | 575 | 18,739 | 44,952 | 45.5 K to 45 K (-1.26 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | J | 0.00 | 384 | 0 | 45,527 | 45.1 K to 45.5 K (+0.85 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,197 | 0 | 45,143 | 43.9 K to 45.1 K (+2.72 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 32.64 | 690 | 22,522 | 43,946 | 44.6 K to 43.9 K (-1.55 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | J | 0.00 | 404 | 0 | 44,636 | 44.2 K to 44.6 K (+0.91 %) |
| Mar 05 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 1,493 | 0 | 44,232 | 42.7 K to 44.2 K (+3.49 %) |
| Jan 04 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
| Jan 04 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Payment of Exercise | F | 35.01 | 3,579 | 125,301 | 42,739 | 46.3 K to 42.7 K (-7.73 %) |
| Jan 04 2012 | BMY | BRISTOL MYERS SQUI ... | Caforio Giovanni | Pres., US Pharmaceu ... | Buy | M | 0.00 | 7,500 | 0 | 46,318 | 38.8 K to 46.3 K (+19.32 %) |
Page: 1